These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 15084133)
1. Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning. Stewart AO; Cowart MD; Moreland RB; Latshaw SP; Matulenko MA; Bhatia PA; Wang X; Daanen JF; Nelson SL; Terranova MA; Namovic MT; Donnelly-Roberts DL; Miller LN; Nakane M; Sullivan JP; Brioni JD J Med Chem; 2004 Apr; 47(9):2348-55. PubMed ID: 15084133 [TBL] [Abstract][Full Text] [Related]
2. Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction. Cowart M; Latshaw SP; Bhatia P; Daanen JF; Rohde J; Nelson SL; Patel M; Kolasa T; Nakane M; Uchic ME; Miller LN; Terranova MA; Chang R; Donnelly-Roberts DL; Namovic MT; Hollingsworth PR; Martino BR; Lynch JJ; Sullivan JP; Hsieh GC; Moreland RB; Brioni JD; Stewart AO J Med Chem; 2004 Jul; 47(15):3853-64. PubMed ID: 15239663 [TBL] [Abstract][Full Text] [Related]
3. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and activity of 2-[4-(4-[3H]-2-cyanophenyl)piperazinyl]-N-(2,4,6-[3H]3-3-methylphenyl)acetamide: a selective dopamine D4 receptor agonist and radioligand. Matulenko MA; Surber B; Fan L; Kolasa T; Nakane M; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Moreland RB; Brioni JD; Stewart AO Bioorg Med Chem Lett; 2004 Oct; 14(20):5095-8. PubMed ID: 15380206 [TBL] [Abstract][Full Text] [Related]
5. 1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction. Kolasa T; Matulenko MA; Hakeem AA; Patel MV; Mortell K; Bhatia P; Henry R; Nakane M; Hsieh GC; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Hollingsworth PR; Martino B; El Kouhen O; Marsh KC; Wetter JM; Moreland RB; Brioni JD; Stewart AO J Med Chem; 2006 Aug; 49(17):5093-109. PubMed ID: 16913699 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists. Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206 [TBL] [Abstract][Full Text] [Related]
7. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist. Nakane M; Cowart MD; Hsieh GC; Miller L; Uchic ME; Chang R; Terranova MA; Donnelly-Roberts DL; Namovic MT; Miller TR; Wetter JM; Marsh K; Stewart AO; Brioni JD; Moreland RB Neuropharmacology; 2005 Jul; 49(1):112-21. PubMed ID: 15992586 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs. Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022 [TBL] [Abstract][Full Text] [Related]
9. 2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist. Enguehard-Gueiffier C; Hübner H; El Hakmaoui A; Allouchi H; Gmeiner P; Argiolas A; Melis MR; Gueiffier A J Med Chem; 2006 Jun; 49(13):3938-47. PubMed ID: 16789750 [TBL] [Abstract][Full Text] [Related]
17. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist. Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061 [TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist. Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors. Andrić D; Roglić G; Sukalović V; Soskić V; Kostić-Rajacić S Eur J Med Chem; 2008 Aug; 43(8):1696-705. PubMed ID: 18006194 [TBL] [Abstract][Full Text] [Related]
20. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands. Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]